Market Shifts: AI Chips, Pharma Giants, and Crypto Valuation
Analysis of cross-sector market movements reveals decisive shifts toward capital efficiency, technological moats, and fundamental valuation frameworks. Strategic vendor lock-in, pharmaceutical pricing power, and digital asset maturation are redefining competitive landscapes. Executives must prioritize scalable revenue models and disciplined capital deployment.